Search
Search Results
##search.searchResults.foundPlural##
-
PREVENTION OF POST-TRANSFUSION HEPATITIS BY SCREENING OF ANTIBODY TO HEPATITIS B CORE ANTIGEN IN HEALTHY BLOOD DONORS
1133PDF: 661HTML: 1236Title page: 184 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
599PDF: 427HTML: 81 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2780PDF: 951HTML: 3113flowcytometric result of peripheral blood sample: 162 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
965PDF: 537HTML: 67 -
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
1560PDF: 762HTML: 800tile page: 148Table 1: 152 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4197PDF: 1154HTML: 2136Figure 1: 152 -
-
Severe Acute Hepatitis B Treated with Entecavir
1482PDF: 767HTML: 2463Figure: 156Title page: 163disclosure: 93 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1146PDF: 773HTML: 1760 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2147PDF: 1177HTML: 3698 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1595PDF: 877HTML: 1861Untitled: 183Untitled: 165 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
819PDF: 480HTML: 1290 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
891PDF: 1054Suppl. Files: 134HTML: 64 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
5999PDF: 3195HTML: 8998Figure Malaria Ricci: 214 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3086PDF: 1792HTML: 3558 -
PROPHYLAXIS OF MALARIA
2970PDF: 1002HTML: 17783Figures SChwartz: 152 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1830PDF: 675HTML: 225 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
89PDF: 90Suppl. Files: 18HTML: 10 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1347PDF: 1281HTML: 84 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3974PDF: 1021HTML: 3571Untitled: 168Cneo. Fig.1: 104Untitled: 94Untitled: 118Untitled: 121 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1504PDF: 1173HTML: 173 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3274PDF: 1220HTML: 2184 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1116PDF: 894HTML: 337 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1233PDF: 518HTML: 23019 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4271PDF: 1466HTML: 1536Untitled: 212 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2396PDF: 901HTML: 500 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1173PDF: 698HTML: 1219 -
SERO PREVALENCE OF TOXARA CANIS IN THE CITY OF CATANIA, ITALY.
1341PDF: 922HTML: 213 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
911PDF: 561HTML: 2180Cover Letter: 178







